✦ LIBER ✦

Effectiveness of Transition from Intravenous Epoprostenol to Oral/Inhaled Targeted Pulmonary Arterial Hypertension Therapy in Pediatric Idiopathic and Familial Pulmonary Arterial Hypertension

✍ Scribed by Laura Melnick; Robyn J. Barst; Cherise A. Rowan; Diane Kerstein; Erika B. Rosenzweig

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transition of Stable Pediatric Patients

✍ D. Dunbar Ivy; Lori Claussen; Aimee Doran 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Safety and Efficacy of Transition from S

✍ Vinicio A. de Jesus Perez; Erica Rosenzweig; Lewis J. Rubin; David Poch; Abubakr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Continuous intravenous iloprost to rever

✍ Ralf Ewert; Christian F. Opitz; Roland Wensel; Jörg Winkler; Michael Halank; Ste 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 190 KB

Long-term Follow-up After Conversion fro

✍ Roger F. Johnson; James E. Loyd; Amy L. Mullican; Cynthia A. Fink; Ivan M. Robbi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Safety and Efficacy of Transition From S

✍ Anne M. Keogh; Andrew Jabbour; Robert Weintraub; Karen Brown; Chris S. Hayward; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Long-term outcome and effects of oral bo

✍ Hsao-Hsun Hsu; Jin-Shing Chen; Robert J. Chen; Wen-Je Ko; Shuenn-Wen Kuo; En-Tin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 221 KB